MOG and MBP peptides are used in EAE induction because multiple sclerosis patients have high levels of anti-MOG and anti-MBP antibodies, justifying the use of these factors for EAE induction in animal models [21]. The gene discussed is MOG; the disease is multiple sclerosis.